A case-control study of gallstones: a major risk factor for biliary tract cancer.

Pharmacokinetic Study of Adjuvant Gemcitabine Therapy for Biliary Tract Cancer following Major Hepatectomy (KHBO1101).

Reproductive factors and risk of biliary tract cancer in a population-based study.

Cholecystectomy for biliary colic without gallstones.

Targeted therapy for biliary tract cancer.

Biliary drug lithiasis: dipyridamole gallstones.

Biliary-tract cancer in Chile.

Molecular profiling of biliary tract cancer: a target rich disease.

Travel style is a major risk factor for diarrhoea in India: a prospective cohort study.

A pilot study of S-1-based concurrent chemoradiotherapy in patients with biliary tract cancer.

A structural study of gallstones.

Anticholinergic Use Is a Major Risk Factor for Dysphonia.

Increased Risk of Peptic Ulcers Following a Cholecystectomy for Gallstones.

Genetics: genetics of biliary tract cancer.

Family History as a Risk for Upper Gastrointestinal Tract Cancer: A Case Control Study.

Optimum chemotherapy for the management of advanced biliary tract cancer.

Evaluation of maternal urinary tract infection as a potential risk factor for neonatal urinary tract infection.

Premature ovarian failure is a major risk factor for cancer-related sexual dysfunction.

Rhabdomyosarcoma of biliary tract- a diagnostic dilemma.

Dietary impact on biliary lipids and gallstones.

New and emerging treatment options for biliary tract cancer.

Disappearing "gallstones": biliary pseudolithiasis complicating ceftriaxone therapy.

BINGO: targeted therapy for advanced biliary-tract cancer.

Spontaneous external biliary fistula uncomplicated by gallstones.

The efficacy of biliary and serum macrophage inhibitory cytokine-1 for diagnosing biliary tract cancer.

Suggest Documents

Pharmacokinetic Study of Adjuvant Gemcitabine Therapy for Biliary Tract Cancer following Major Hepatectomy (KHBO1101).

Reproductive factors and risk of biliary tract cancer in a population-based study.

Cholecystectomy for biliary colic without gallstones.

Targeted therapy for biliary tract cancer.

Biliary drug lithiasis: dipyridamole gallstones.

Biliary-tract cancer in Chile.

Molecular profiling of biliary tract cancer: a target rich disease.

Travel style is a major risk factor for diarrhoea in India: a prospective cohort study.

A pilot study of S-1-based concurrent chemoradiotherapy in patients with biliary tract cancer.

A structural study of gallstones.

Anticholinergic Use Is a Major Risk Factor for Dysphonia.

Increased Risk of Peptic Ulcers Following a Cholecystectomy for Gallstones.

Genetics: genetics of biliary tract cancer.

Family History as a Risk for Upper Gastrointestinal Tract Cancer: A Case Control Study.

Optimum chemotherapy for the management of advanced biliary tract cancer.

Evaluation of maternal urinary tract infection as a potential risk factor for neonatal urinary tract infection.

Premature ovarian failure is a major risk factor for cancer-related sexual dysfunction.

Rhabdomyosarcoma of biliary tract- a diagnostic dilemma.

Dietary impact on biliary lipids and gallstones.

New and emerging treatment options for biliary tract cancer.

Disappearing "gallstones": biliary pseudolithiasis complicating ceftriaxone therapy.

BINGO: targeted therapy for advanced biliary-tract cancer.

Spontaneous external biliary fistula uncomplicated by gallstones.

The efficacy of biliary and serum macrophage inhibitory cytokine-1 for diagnosing biliary tract cancer.

A case-control study of gallstones: a major risk factor for biliary tract cancer.

Recommend Documents

Follow Us